Tomas J. Heyman - Sep 15, 2022 Form 3 Insider Report for Xilio Therapeutics, Inc. (XLO)

Role
Director
Signature
/s/ Chris Frankenfield, Attorney-in-Fact
Stock symbol
XLO
Transactions as of
Sep 15, 2022
Transactions value $
$0
Form type
3
Date filed
9/16/2022, 04:50 PM
Previous filing
Jun 24, 2022
Next filing
May 25, 2023

No securities are beneficially owned.